NATIONAL RESEARCH CORP (NRC)
US6373722023 - Common Stock
Taking everything into account, NRC scores 6 out of 10 in our fundamental rating. NRC was compared to 108 industry peers in the Health Care Providers & Services industry. NRC gets an excellent profitability rating and is at the same time showing great financial health properties. NRC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NRC was profitable.
In the past year NRC had a positive cash flow from operations.
Each year in the past 5 years NRC has been profitable.
NRC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NRC has a better Return On Assets (20.54%) than 100.00% of its industry peers.
With an excellent Return On Equity value of 78.20%, NRC belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
NRC's Return On Invested Capital of 30.89% is amongst the best of the industry. NRC outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 8.15%.
The 3 year average ROIC (38.44%) for NRC is well above the current ROIC(30.89%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.54% | ||
| ROE | 78.2% | ||
| ROIC | 30.89% |
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)38.44%
ROIC(5y)38.36%
1.3 Margins
NRC has a better Profit Margin (18.78%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
The Operating Margin of NRC (26.12%) is better than 100.00% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
NRC has a Gross Margin of 60.89%. This is amongst the best in the industry. NRC outperforms 85.19% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.12% | ||
| PM (TTM) | 18.78% | ||
| GM | 60.89% |
OM growth 3Y-5.19%
OM growth 5Y-1.76%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
NRC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for NRC has been reduced compared to 5 years ago.
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.09 indicates that NRC is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.09, NRC belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
The Debt to FCF ratio of NRC is 2.13, which is a good value as it means it would take NRC, 2.13 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.13, NRC belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that NRC has dependencies on debt financing.
With a Debt to Equity ratio value of 1.44, NRC is not doing good in the industry: 71.30% of the companies in the same industry are doing better.
Although NRC does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 2.13 | ||
| Altman-Z | 4.09 |
ROIC/WACC3.56
WACC8.67%
2.3 Liquidity
NRC has a Current Ratio of 0.47. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a worse Current ratio (0.47) than 91.67% of its industry peers.
A Quick Ratio of 0.47 indicates that NRC may have some problems paying its short term obligations.
The Quick ratio of NRC (0.47) is worse than 90.74% of its industry peers.
NRC does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased by -3.12% in the last year.
NRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.24% yearly.
The Revenue has decreased by -3.07% in the past year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-3.12%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-25.14%
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-5.62%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 13.74, which indicates a correct valuation of NRC.
NRC's Price/Earnings ratio is rather cheap when compared to the industry. NRC is cheaper than 82.41% of the companies in the same industry.
NRC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.74 | ||
| Fwd PE | N/A |
4.2 Price Multiples
NRC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NRC is cheaper than 74.07% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NRC is valued cheaply inside the industry as 80.56% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.01 | ||
| EV/EBITDA | 10.28 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.24
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NRC has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
The stock price of NRC dropped by -20.66% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.83, NRC pays a better dividend. On top of this NRC pays more dividend than 93.52% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, NRC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.81% |
5.2 History
The dividend of NRC is nicely growing with an annual growth rate of 16.85%!
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
NRC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.85%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
NRC pays out 42.78% of its income as dividend. This is a bit on the high side, but may be sustainable.
NRC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP42.78%
EPS Next 2YN/A
EPS Next 3YN/A
NATIONAL RESEARCH CORP
NASDAQ:NRC (12/20/2024, 8:00:01 PM)
After market: 17.17 0 (0%)17.17
+0.1 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.36%
Inst Owner Change-0.42%
Ins Owners0.62%
Ins Owner Change0%
Market Cap403.15M
Analysts45
Price TargetN/A
Short Float %2.31%
Short Ratio3.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.81% |
Dividend Growth(5Y)16.85%
DP42.78%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.74 | ||
| Fwd PE | N/A | ||
| P/S | 2.8 | ||
| P/FCF | 16.01 | ||
| P/OCF | 10.09 | ||
| P/B | 11.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.28 |
EPS(TTM)1.25
EY7.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.07
FCFY6.24%
OCF(TTM)1.7
OCFY9.91%
SpS6.14
BVpS1.47
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)4.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.54% | ||
| ROE | 78.2% | ||
| ROCE | 43.03% | ||
| ROIC | 30.89% | ||
| ROICexc | 32.09% | ||
| ROICexgc | 141.93% | ||
| OM | 26.12% | ||
| PM (TTM) | 18.78% | ||
| GM | 60.89% | ||
| FCFM | 17.46% |
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)38.44%
ROIC(5y)38.36%
ROICexc(3y)54.35%
ROICexc(5y)53.24%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)50.64%
ROCE(5y)50.54%
ROICexcg growth 3Y-21.81%
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-7.33%
OM growth 3Y-5.19%
OM growth 5Y-1.76%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%
F-Score4
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 2.13 | ||
| Debt/EBITDA | 1.14 | ||
| Cap/Depr | 248.91% | ||
| Cap/Sales | 10.25% | ||
| Interest Coverage | 19.8 | ||
| Cash Conversion | 91.64% | ||
| Profit Quality | 92.99% | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.47 | ||
| Altman-Z | 4.09 |
F-Score4
WACC8.67%
ROIC/WACC3.56
Cap/Depr(3y)180.12%
Cap/Depr(5y)135.49%
Cap/Sales(3y)6.94%
Cap/Sales(5y)5.49%
Profit Quality(3y)88.14%
Profit Quality(5y)95.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.12%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-25.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.07%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-5.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.07%
EBIT growth 3Y-1.7%
EBIT growth 5Y2.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.86%
FCF growth 3Y-15.23%
FCF growth 5Y-8%
OCF growth 1Y-0.7%
OCF growth 3Y-2.12%
OCF growth 5Y-0.89%